We are live on ! Find out more
CMND icon

Clearmind Medicine
CMND

6 hedge funds and large institutions have $5.49M invested in Clearmind Medicine in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% less capital invested

Capital invested by funds: $5.49M → $5.49M (-$3.11K)

3.31% less ownership

Funds ownership: 17.3% → 13.99% (-3.3%)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$53.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$26.6K
3
GAM
Gotham Asset Management
New York
+$4.43K
4
Morgan Stanley
Morgan Stanley
New York
+$4.43K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$172K
2
HF
HRT Financial
New York
-$15K
3
AI
AdvisorShares Investments
Maryland
-$4.43K

CMND Hedge Fund Activity: Q4 2024 in Review

6 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q4 2024, worth a combined $5.49M — down 0.06% from $5.49M a quarter earlier.

Fund positioning in CMND was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $53.2K. The largest seller was UBS Group, exiting entirely with an estimated $172K sold.

  • 6 institutional investors held Clearmind Medicine (CMND) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $5.49M of Clearmind Medicine stock for Q4 2024, down 0.06% quarter-over-quarter.
  • 2 funds opened new Clearmind Medicine positions in Q4 2024 and 2 closed out, a net change of 0 holders.
  • The largest Clearmind Medicine buyer in Q4 2024 was Virtu Financial, an estimated $53.2K added.
  • The largest Clearmind Medicine seller in Q4 2024 was UBS Group, an estimated $172K sold.

Based on aggregated 13F filings for Q4 2024.